History & Awards
Company History
Time | Achievement | ||||||
---|---|---|---|---|---|---|---|
2015 | Algapharma Biotech Corp.( Subsidiary company) obtained Bronze Award of “2015 Taiwan Healthcare and Agricultural Biotech Industries and Excellence Award.
| ||||||
2014 | • CV-66 application as immune adjustment health food is officially received by SFDA. • Apomivir® grants TW FDA IND approval for phase II clinical trials. | ||||||
2013 | LS-66® Major Function Approved and Certified By The Taiwan Department of Health (No. A00241). | ||||||
2012 | Bpogen® spirulina capsule receives innovative award from Health Food Society of Taiwan.
| ||||||
2011 | • Scientific and Technological Agribusiness Awards by Council of Agriculture, Executive Yuan. • FEBICO is nominated for both Innovative Research category and Technology Application category.
| ||||||
2010 | • FEBICO obtained CAITA Innovative Enterprise Award. • FEBICO obtained BioTaiwan Innovation and Excellence Award. • FEBICO obtained Ministry of Economic Affairs. • FEBICO obtained SME Innovative Award.
| ||||||
2009 | FEBICO was nominated in the most honorable 2009 Taipei Biotech awards, and was awarded with Technology Commercialization Silver award.
| ||||||
2008 | Apogen® received Taiwanese patent for a method for Inhibiting Enterovirus and/or Influenza Virus reproduction by Allophycocyanin in vitro.
| ||||||
2007 | Apogen® prevents Influenza type A and type B virus infection and replication in a cocktail treatment. (R.O.C Patent I-272947)
| ||||||
2006 | Obtained the SBIR program compensation from The Dept. of Industrial Technology (DoIT) of Ministry of Economic Affairs (MOEA) in Taiwan. | ||||||
2005 | • Oral dosage of Apogen can prevent viral infection. (R.O.C. patent I 240631) • National Quality Award for Certified Organic Spirulina and “Certificate of Symbol for National Quality”. Both awards recognize the continued excellence in the quality of FEBICO Premium Organic Spirulina. • Organic chlorella and Spirulina certified by Chinese Organic Agricertification Association.
| ||||||
2004 | • Apogen® Children Granules received Nutraceutical Innovation Award approved by Health Food Society of Taiwan. • FEBICO signed contract to collaborate with HungKuang University
| ||||||
2003 | • Publish research studies with Chang Gung University • Formal introduction of Apogen in the market • Research grant approved from Ministry of Economic Affairs, R.O.C. • Cracked Chlorella Cell Wall (R.O.C. Patent: 183428)
| ||||||
2002 | • Organic Spirulina Certification (NL-RC-1309-B) • Apogen® is effective in preventing enterovirus 71 and influenza A, B infection (U.S. patent 6346408 ) • Received research grant from SBIR program from SMEA of Ministry of Economic Affairs in Taiwan. | ||||||
2001 | Initiated development of microalgae specialized protein in cancer diagnostics. | ||||||
2000 | Successfully develop phycobiliproteins for immunology research use. | ||||||
1998 | Initiated microalgae biomedical research. | ||||||
1995 | Initiation of microalgae phycobiliproteins development. | ||||||
1990 | Establishment of FEBICO microalgae lab. Joint collaboration with FEMICO to develop high valued microalgae product. | ||||||
1976 | FEMICO (Far East Microalgae Industries, Co., Ltd) was founnded in 1976. |